| dc.contributor.author | Kalcioglu, MT | |
| dc.contributor.author | Kuku, I | |
| dc.contributor.author | Kaya, E | |
| dc.contributor.author | Oncel, S | |
| dc.contributor.author | Aydogdu, I | |
| dc.date.accessioned | 2022-03-16T08:29:59Z | |
| dc.date.available | 2022-03-16T08:29:59Z | |
| dc.date.issued | 2003 | |
| dc.identifier.uri | http://hdl.handle.net/11616/55942 | |
| dc.description.abstract | Vincristine sulfate is a chemotherapeutic agent used in different cancer therapies. It is also the first choice of treatment for peripheral T-cell lymphoma with cyclophosphamide and adriamycin. Sudden hearing loss during vincristine therapy is a very rare event. This is a case of a 16-year old girl who developed sudden bilateral hearing loss related to vincristine therapy. | |
| dc.source | JOURNAL OF CHEMOTHERAPY | |
| dc.title | Bilateral hearing loss during vincristine therapy: A case report |
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||